YOLFTbeta
41

Tien Liang BioTech Co., Ltd.

4127 · TWO · Healthcare / Drug Manufacturers - Specialty & Generic

34.80TWD-0.40 (-1.14%)

Price History

Full chart

Market Stats

Previous Close35.20
Open35.95
Day Range34.70 – 36.25
52-Week Range29.00 – 96.00
Volume94.61K
Market Cap2.09B
P/E (TTM)30.20
Forward P/E0.00
EPS1.51
Dividend Yield0.00%
Beta0.82
50-Day Avg70.62
200-Day Avg52.77

About

Tien Liang BioTech Co., Ltd. manufactures and sells pharmaceutical products in Taiwan. The company offers Chinese and Western medicine, other healthcare, and cosmetic products through online and offline channels. Tien Liang BioTech Co., Ltd. was founded in 1971 and is based in New Taipei City, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOJunxiong Guo
  • Employees88
  • HeadquartersNo. 147, Datong Road, New Taipei City, Taiwan, Taiwan
  • Websitehttps://www.tlb.com.tw

Leadership

  • Junxiong GuoFinance Manager & Accounting Supervisor

Financials

Income Statement

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue435.86M431.08M571.32M528.52M459.99M385.21M511.79M
Growth (%)--1.10%+32.53%-7.49%-12.97%-16.26%+32.86%
Cost of Revenue194.03M179.13M233.04M191.98M173.84M155.29M223.86M
Gross Profit241.83M251.96M338.28M336.55M286.15M229.91M287.94M
Gross Margin55.48%58.45%59.21%63.68%62.21%59.69%56.26%
Operating Expense285.25M298.59M287.64M275.44M265.71M229.32M304.08M
Operating Income-43.42M-46.63M50.63M61.10M20.44M593.00K-16.14M
Operating Margin-9.96%-10.82%8.86%11.56%4.44%0.15%-3.15%
EBITDA-21.55M-31.79M63.06M72.15M31.05M25.49M9.45M
EBITDA Margin-4.95%-7.37%11.04%13.65%6.75%6.62%1.85%
Net Income-46.78M-51.64M46.60M59.48M17.73M11.70M-10.25M
Net Income Margin-10.73%-11.98%8.16%11.25%3.85%3.04%-2.00%
R&D991.00K1.24M1.20M1.40M1.28M2.48M4.58M
R&D as % of Total Revenue0.23%0.29%0.21%0.26%0.28%0.64%0.89%
Interest Expense2.62M1.96M1.85M1.77M2.08M3.08M11.13M
Interest Expense % of Total Revenue0.60%0.46%0.32%0.34%0.45%0.80%2.17%

Balance Sheet

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-624.94M655.35M676.43M654.03M888.68M1.18B
Total Liabilities-257.68M241.30M201.30M161.05M410.76M709.19M
Total Equity-367.25M414.05M475.13M492.98M477.92M474.04M
Cash54.48M115.24M118.47M107.84M142.22M130.67M122.31M
Total Debt-184.31M156.87M114.13M84.66M345.20M-
Net Debt-54.48M69.08M38.40M6.29M-57.56M214.53M476.23M

Cash Flow

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow--10.82M45.21M21.88M69.67M48.34M19.23M
Financing Cash Flow-38.41M-40.80M-31.30M-30.52M241.62M-
Capital Expenditure01.49M597.00K1.01M5.34M4.14M23.33M
Free Cash Flow--12.31M44.61M20.87M64.33M44.20M-4.09M
Dividends Paid-----22.88M-
FCF to OCF-113.79%98.68%95.38%92.33%91.44%-21.29%
Dividend Paid to FCF-----51.76%-

Earnings

Report DateAug 14, 2015Nov 16, 2015
EPS Estimate0.500.46
EPS Actual0.350.13
Surprise-30.00%-71.74%
TimingPre-market-

Key Statistics & Ratios

Market Cap2.09B
Enterprise Value2.67B
Trailing P/E30.20
Forward P/E0.00
Price / Sales3.21
Price / Book4.37
EPS1.51
Book Value11.35
Revenue (TTM)650.87M
Gross Profit (TTM)379.37M
EBITDA16.56M
Profit Margin10.62%
Operating Margin5.31%
Return on Equity14.25%
Return on Assets0.31%
Shares Outstanding45.76M
Shares Float2.00M
Beta0.82
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20241×
0.50Aug 27, 2024
20161×
0.30Jul 14, 2016
20151×
0.70Jul 8, 2015
20141×
1.00Jul 25, 2014
20131×
0.20Jul 3, 2013
20101×
0.20Jul 13, 2010
20091×
0.15Sep 22, 2009
20081×
0.10Sep 24, 2008

Stock Splits

  • Sep 24, 2008104:100